Eleven early onset patients with BC (14%) had PVs or LPVs mutations in BRCA1 or BRCA2 genes, whereas 17 patients (11%) reported mutations in one of the other genes included in the multi-gene panel. This evidence concerns the gene BRCA1 and breast cancer.